Which influenza vaccine is more effective in children aged 2–6 years?

Prepare for the American Board of Family Medicine Exam. Study with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Which influenza vaccine is more effective in children aged 2–6 years?

Explanation:
In children aged 2–6 years, the vaccine that mimics a natural infection in the respiratory tract tends to provide stronger protection because it stimulates mucosal immunity in addition to systemic immunity. The live attenuated intranasal vaccine replicates in the nasal passages, triggering mucosal IgA along with broader immune responses. This local defense at the site where influenza first enters helps reduce infection and transmission more effectively in this age group than an injected inactivated vaccine, which mainly prompts systemic antibodies. The intranasal option also has practical advantages that can improve uptake in young children. For these reasons, the live attenuated intranasal influenza vaccine is the better choice for children 2–6 years old.

In children aged 2–6 years, the vaccine that mimics a natural infection in the respiratory tract tends to provide stronger protection because it stimulates mucosal immunity in addition to systemic immunity. The live attenuated intranasal vaccine replicates in the nasal passages, triggering mucosal IgA along with broader immune responses. This local defense at the site where influenza first enters helps reduce infection and transmission more effectively in this age group than an injected inactivated vaccine, which mainly prompts systemic antibodies. The intranasal option also has practical advantages that can improve uptake in young children. For these reasons, the live attenuated intranasal influenza vaccine is the better choice for children 2–6 years old.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy